All in Podcast
@allin·1.1M subscribers·933 videos
Dave Ricks, CEO of Eli Lilly | The All-In Interview
Posted
October 8, 2024
Views
117,956
Likes
2,720
Comments
306
Engagement
2.57%
October 8, 2024
117,956
2,720
306
2.57%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:04:57Now Playing(0:00) Friedberg welcomes Eli Lilly CEO Dave Ricks
(2:06) The obesity problem: a global chronic health epidemic
(13:07) The history of discovering GLP-1s
(20:38) Impact of GLP-1s on different human functions
(27:09) Understanding the commercial aspect of drug discovery, pricing for GLP-1 drugs
(33:11) Responding to criticism and research of GLP-1 dependency
(40:04) Stock performance, dealing with political pressure related to successful drugs
(47:19) Eli Lilly's portfolio of drugs outside of GLP-1s, what science Dave is excited about
(56:09) Scaling and impacting culture at a 100+ year-old company
Follow the besties:
Follow on X:
Follow on Instagram:
Follow on TikTok:
Follow on LinkedIn:
Intro Music Credit:
Intro Video Credit:
Referenced in the show:
#allin #tech #news
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
